Tasly Pharmaceutical Group Dividend
Dividend criteria checks 5/6
Tasly Pharmaceutical Group is a dividend paying company with a current yield of 2.56% that is well covered by earnings.
Key information
2.6%
Dividend yield
45%
Payout ratio
Industry average yield | 1.9% |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | n/a |
Earnings per share | CN¥0.74 |
Dividend yield forecast in 3Y | 3.2% |
Recent dividend updates
No updates
Recent updates
Estimating The Intrinsic Value Of Tasly Pharmaceutical Group Co., Ltd (SHSE:600535)
Jun 13The Market Doesn't Like What It Sees From Tasly Pharmaceutical Group Co., Ltd's (SHSE:600535) Earnings Yet
May 13Tasly Pharmaceutical Group's (SHSE:600535) Solid Earnings Have Been Accounted For Conservatively
Apr 26Does Tasly Pharmaceutical Group (SHSE:600535) Have A Healthy Balance Sheet?
Mar 15Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 600535's dividend payments have been volatile in the past 10 years.
Growing Dividend: 600535's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
Tasly Pharmaceutical Group Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (600535) | 2.6% |
Market Bottom 25% (CN) | 0.7% |
Market Top 25% (CN) | 2.5% |
Industry Average (Pharmaceuticals) | 1.9% |
Analyst forecast in 3 Years (600535) | 3.2% |
Notable Dividend: 600535's dividend (2.56%) is higher than the bottom 25% of dividend payers in the CN market (0.69%).
High Dividend: 600535's dividend (2.56%) is in the top 25% of dividend payers in the CN market (2.54%)
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (44.8%), 600535's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonably low cash payout ratio (31.8%), 600535's dividend payments are well covered by cash flows.